Evidence map›Paper›PMID 26224613›Full record

Trial reportInternational orthopaedics2015

A randomized study of autologous conditioned plasma and steroid injections in the treatment of lateral epicondylitis.

Radosław Lebiedziński, Marek Synder, Piotr Buchcic, Michał Polguj, Andrzej Grzegorzewski, Marcin Sibiński

Open access · hybridAbstract readComparative StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in International orthopaedics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 5 pooled it
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 5 syntheses or guidelines pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Platelet-rich plasma in tendon-related disorders: results and indications.Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2018
    Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Radosław LebiedzińskiClinic of Orthopaedics and Paediatric Orthopaedics Medical University of Łódź, Pomorska 251, 92-213, Łodź, Poland.
Marek SynderClinic of Orthopaedics and Paediatric Orthopaedics Medical University of Łódź, Pomorska 251, 92-213, Łodź, Poland.
Piotr BuchcicClinic of Orthopaedics and Paediatric Orthopaedics Medical University of Łódź, Pomorska 251, 92-213, Łodź, Poland.
Michał PolgujDepartment of Angiology, Chair of Anatomy, Medical University of Łódź, 91-002, Łódź, Poland.
Andrzej GrzegorzewskiClinic of Orthopaedics and Paediatric Orthopaedics Medical University of Łódź, Pomorska 251, 92-213, Łodź, Poland.
Marcin SibińskiClinic of Orthopaedics and Paediatric Orthopaedics Medical University of Łódź, Pomorska 251, 92-213, Łodź, Poland. sibinek@poczta.onet.pl.
Medical University of Lodz · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeChronic tendinopathy of lateral epicondyle of the humerus, commonly known as "tennis elbow" is one of the most frequent tendinopathies caused by recurrent overload of the muscle origins. The aim of the study was to assess the effectiveness of treating lateral epicondylitis (LE) with autologous conditioned plasma (ACP) and betamethasone injections, and to compare these methods over the course of a one year follow-up.

methodsPatients were randomly placed into one of into two groups: 53 were treated with ACP, and 46 with 1 ml betamethasone injections and 2 ml of 1 % lignocaine. Both those groups were comparable in terms of initial DASH score.

resultsAfter six weeks and six months, the mean DASH score was significantly better in the betamethasone group, but was better in ACP group after one year. Full recovery (patients with no symptoms) at all time points was more common in the betamethasone group. A comparison of grouped DASH scores revealed more very good and good results in the ACP group after one year. More patients had pain symptoms related to injection in the ACP group than the betamethasone group.

conclusionsACP therapy of LE allows better results to be obtained at 12 months. Betamethasone injections give more rapid improvement, but the therapeutic effect is longer lasting in the ACP group.

Indexed as

Platelet-Rich PlasmaAdultAgedAged, 80 and overBetamethasoneFemaleFollow-Up StudiesGlucocorticoidsHumansInjectionsMaleMiddle AgedPain MeasurementProspective StudiesTennis ElbowTransplantation, AutologousBetamethasoneGlucocorticoidsACPConservative treatmentPRPSteroidsTennis elbow

Identifiers

PMID26224613
OpenAlexW1615342283

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.